Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis
The inhibition of pyrimidine biosynthesis by blocking the dihydroorotate dehydrogenase (DHODH) activity, the prime target of leflunomide (LEF), has been proven to be an effective strategy for rheumatoid arthritis (RA) treatment. However, a considerable proportion of RA patients are refractory to LEF...
मुख्य लेखकों: | Peres, RS, Santos, GB, Cecilio, NT, Jabor, VAP, Niehues, M, Torres, BGS, Buqui, G, Silva, CHTP, Costa, TD, Lopes, NP, Nonato, MC, Ramalho, FS, Louzada-Júnior, P, Cunha, TM, Cunha, FQ, Emery, FS, Alves-Filho, JC |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
BioMed Central
2017
|
समान संसाधन
-
Pharmacological opportunities to control inflammatory diseases through inhibition of the leukocyte recruitment
द्वारा: Peres, RS, और अन्य
प्रकाशित: (2016) -
Determination of Photosensitizing Potential of Lapachol for Photodynamic Inactivation of Bacteria
द्वारा: Regiane G. Lima, और अन्य
प्रकाशित: (2024-11-01) -
ANTHELMINTIC ACTIVITY OF LAPACHOL, β-LAPACHONE AND ITS DERIVATIVES AGAINST Toxocara canis LARVAE
द्वारा: Taís MATA-SANTOS, और अन्य
प्रकाशित: (2015-06-01) -
Citrullinated human fibrinogen triggers arthritis through an inflammatory response mediated by IL-23/IL-17 immune axis
द्वारा: Saraiva, AL, और अन्य
प्रकाशित: (2021) -
Cytotoxicity and In Vitro Antileishmanial Activity of Antimony (V), Bismuth (V), and Tin (IV) Complexes of Lapachol
द्वारा: Marcele Neves Rocha, और अन्य
प्रकाशित: (2013-01-01)